Brand Story
03 Jun 2023, 10:59 GMT+10
A new study by Fact.MR reveals that the global CBD market is likely to grow by over 40% in 2019 from 2018. The global CBD market is anticipated to have a positive growth in the forecast period owing to the growing awareness about therapeutic benefits of CBD, decrease in the social stigma against the cannabis and countries taking initiation towards legalization of some of the varieties of cannabis derivatives like CBD.
In the last 30 years, around 50 countries have legalized some form of cannabis by virtue of its potency against various illnesses like Crohn's disease, epilepsy, glaucoma, and nausea. The increase in the geriatric population across the globe has bolstered the requirement of medical cannabis for pain-relieving purposes. All of this has rapidly changed the consumer mind-set regarding cannabis and its derivatives. The consumer now regards cannabis as a therapeutic instead of a psychotropic ingredient. These changes have led to many companies getting attracted to growing cannabis and selling for both medical and recreational purposes. The companies are adopting CBD into various end-user products like Vapes, edibles, and beverages. CBD used in non-conventional products had a market share of around 45% in 2018, says the report.
For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=4176
The CBD Market is Establishing Inroads with Ingenious Offerings Within the Pharmaceutical Industry
According to the report, more than 50% of the U.S. population is living in states where some form of cannabis is statutory. Countries like Canada and Uruguay have incorporated cannabis. Many countries across the globe are steadily accepting medical cannabis, making CBD a new buzzing market phenomenon. Consumers are spoilt for choice with companies providing CBD in various forms like tinctures and edibles. The significant business of cannabis is currently based in North America, which accounts for 2/3rd of the global cannabis market. Europe is showcasing a great premise for the market with sales doubling over the year 2018.
The major companies in the fray are taking intelligent decisions to capture the maximum share of the market. Companies have signed partnerships and agreements with celebrities like Snoop Dogg, Seth Rogan, and Evan Goldberg to promote their products. Various cannabis companies partnered with brands like Constellation and Canada's Greatest Kitchen to innovate cannabis-infused products like alcoholic beverages and chocolates. The larger companies in the market have aggressively acquired petite companies to increase their production capacity. Some of the companies have a business in over 20 countries displaying the potential of Global CBD Market.
In the following decade, manufacturers in the Cannabidiol industry will focus on strategic acquisitions, collaborations, and new launches.
For critical insights on this market, request for methodology here - https://www.factmr.com/connectus/sample?flag=RM&rep_id=4176
Segmentation
The study also shares details on factors impacting pricing strategies of the manufacturers within the global CBD market. Segmentation of the global CBD market provided in the report is briefly delineated in the following segmentation table:
Region
Source
Form
Grade
Application
For in-depth competitive analysis, buy now - https://www.factmr.com/checkout/4176
Medical Services to be a New and Innovative Way of Providing Customer Care in the CBD Market
Fact.MR's study also opines that leading companies like Canopy growth and Hexo have introduced pharmaceutical care services for their customers. In this service, they collect the medical record of the customers and provide them with advice from appointed medical professionals. This advice helps the customer to maintain good health, and the company gains from converted sales and customer loyalty. Companies are spending a significant amount on these services to leverage the data into actionable insights for the company. This data provides the company with customer details and consumption patterns, which is employed in modifying the company's strategies to foray into different verticals of the market.
Get a daily dose of San Francisco Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to San Francisco Star.
More Information© Provided by Xinhua BEIJING, Sept. 21 (Xinhua) -- China's non-financial outbound direct investment (ODI) increased 18.8 percent year on ...
(Photo credit: Bob Frid-USA TODAY Sports) Both captains have acknowledged that the United States is the underdog entering this week's ...
© Provided by Xinhua Over the years, China has led by example by setting out clear carbon reduction goals and ...
© Provided by Xinhua Addressing the climate crisis is no longer optional. It is an immediate necessity.UNITED NATIONS, Sept. 21 ...
© Provided by Xinhua by Burak AkinciANKARA, Sept. 21 (Xinhua) -- Türkiye is extending its tourism season into the fall ...
(Photo credit: Jasen Vinlove-USA TODAY Sports) The Detroit Tigers named Jeff Greenberg as the franchise's 20th general manager on Thursday. ...
SEOUL, South Korea: Thousands of South Korean educators and school staff gathered in Seoul over the weekend to demand increased ...
WARSAW, Poland: As part of European Union (EU) sanctions imposed against Russia over its invasion of Ukraine, Poland banned all ...
MONTGOMERY, Alabama: Last week, Alabama's school chief, Superintendent Eric Mackey, said that under new reading benchmarks to move to fourth ...
WASHINGTON D.C.: Last week, the Federal Reserve said its losses surpassed the US$100 billion mark and will likely continue to ...
ARLINGTON, Virginia: This week, the U.S. State Department approved the potential sale of drone-related munitions and other systems to Canada ...
BETHESDA, Maryland: This week, the US National Institutes of Health (NIH) said that it started early-stage human trials on FluMos-v2, ...